Share
- Release Date: 17/01/13 18:14
- Summary: GENERAL: BLT: FSANZ clears the way for BLIS M18 probiotic use in foods
- Price Sensitive: No
- Download Document 2.66KB
BLT
17/01/2013 16:14
GENERAL
REL: 1614 HRS BLIS Technologies Limited
GENERAL: BLT: FSANZ clears the way for BLIS M18 probiotic use in foods
FSANZ clears the way for BLIS M18(TM) probiotic use in foods
BLIS Technologies Ltd (NZX:BLT) is pleased to advise that it has received a
written acknowledgement from Food Standards Australia New Zealand ('FSANZ')
that its new probiotic, BLIS M18(TM) is not considered by the authority to be
a Novel Food in either Australia or New Zealand. This enables the BLIS
M18(TM) probiotic to be used directly in food applications such as yoghurt
and beverages, in Australia and New Zealand bypassing the demanding and
formal "novel foods" application.
By definition, a novel food is a non-traditional food that has no sufficient
history of safe use and so in making this declaration, FSANZ have
acknowledged the intrinsic safety of the BLIS M18(TM) probiotic in humans, as
well as the safety of the species and the strain that BLIS M18(TM) originates
from.
Novel food ingredients however, can be sold in Australia and New Zealand but
only after they have under gone a rigorous risk and safety assessment by the
researchers and food scientists within FSANZ. Once assessed and deemed to be
safe, these novel foods are then added to the novel foods list, which makes
up the Novel Foods Standard. Only food ingredients that appear on this list
or have been assessed prior to be a non-novel food ingredient (such as the
BLIS M18(TM) and BLIS K12 probiotics) can be legally sold as a food
ingredient, in either Australia or New Zealand.
Dr Barry Richardson, CEO of BLIS Technologies said today, "We welcome the
finding by the Advisory Committee on Novel Foods to indicate the 'non-novel
food' status to BLIS M18(TM). This probiotic, like its partner product BLIS
K12, has an exceptional safety record and has been part of our food supply
for a long time. This decision from FSANZ will now enable us to discuss the
application of both these probiotics with food manufacturers who are seeking
to assist with their consumer's oral health and to fight tooth decay in
children"
About BLIS M18(TM)
BLIS M18(TM) is an oral cavity probiotic, which has been shown to support the
teeth and gums. BLIS M18(TM) is able to protect itself from other invading
bacteria by secreting specific short-chain proteins or peptides known as
"BLIS". BLIS stands for Bacteriocin-Like-Inhibitory- Substances and that
is why BLIS probiotics are sometimes called "Next Generation, Advanced
Probiotics".
YOUR CONTACT:
Dr Barry Richardson
BLIS Technologies Ltd
PO Box 56 ?87 St David Street ?Dunedin?New Zealand
Phone +64 (3) 479 5337
www.blis.co.nz
End CA:00232121 For:BLT Type:GENERAL Time:2013-01-17 16:14:30
